Associations of DNA Methylation Algorithms of Aging With Cardiovascular Disease and Mortality Risk Among US Older

Xian Cui1, Shiqun Sun2, Hui Zhang3

  • 1Diagnostic Imaging Center, Shanghai Children's Medical Center School of Medicine, Shanghai Jiao Tong University Shanghai 200127 China.

Insights

DNA methylation (DNAm) algorithms like GrimAgeMortacc and GrimAge2Mortacc show promise for predicting cardiovascular disease (CVD) risk and mortality. These epigenetic clocks offer valuable insights for assessing adverse health outcomes in older adults.

Area of Science:

  • Epigenetics
  • Gerontology
  • Cardiovascular Medicine

Background:

  • DNA methylation (DNAm) algorithms are emerging predictors of aging and adverse health outcomes.
  • Existing DNAm algorithms show variable performance in cardiovascular disease (CVD) risk stratification.
  • A systematic investigation is needed to assess the predictive utility of various DNAm algorithms for CVD and mortality risk.

Purpose of the Study:

  • To systematically evaluate the associations of 12 DNAm algorithms with CVD risk.
  • To assess the predictive performance of these algorithms for CVD mortality.
  • To determine the consistency of these associations across demographic subgroups.

Main Methods:

  • Utilized data from the National Health and Nutrition Examination Survey (NHANES) 1999-2002.
  • Assessed 12 DNAm algorithms (e.g., HannumAgeacc, PhenoAgeacc, GrimAgeMortacc, GrimAge2Mortacc) in relation to CVD and mortality risk.
  • Employed multivariable regression models to calculate odds ratios (ORs) and hazard ratios (HRs) per standard deviation increase in DNAm algorithms.

Main Results:

  • GrimAgeMortacc and GrimAge2Mortacc were significantly associated with coronary heart disease and heart attack (ORs 2.15-2.76 per SD).
  • Several algorithms showed significant associations with CVD mortality, including HannumAgeacc, PhenoAgeacc, ZhangAgeacc, GrimAgeMortacc, and GrimAge2Mortacc (HRs 1.13-1.90 per SD).
  • Associations remained consistent across biological sex, age groups, and race/ethnicity.

Conclusions:

  • DNA methylation algorithms, especially GrimAgeMortacc and GrimAge2Mortacc, show potential as tools for CVD risk stratification.
  • These epigenetic markers are valuable for assessing mortality risk associated with cardiovascular conditions.
  • The findings support the use of specific DNAm algorithms in clinical settings for improved risk assessment.
Abstract

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
2.9K
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
22
Telomeres and Telomerase02:41

Telomeres and Telomerase

4.9K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.0K